Vor Biopharma amends and restates 2021 equity incentive plan with expanded share reserve.

Vor Biopharma's board adopted and stockholders approved an amended and restated 2021 Equity Incentive Plan on June 11, 2026, increasing the share reserve to 2.3 million shares plus annual 4% increases through 2035. The expanded plan enhances the company's ability to attract and retain talent through equity compensation.